Log in

NYSEARCA:IHEiShares US Pharmaceuticals ETF Stock Price, Forecast & News

$154.39
+0.25 (+0.16 %)
(As of 07/3/2020 04:00 PM ET)
Add
Today's Range
$154.39
Now: $154.39
$155.82
50-Day Range
$147.75
MA: $153.98
$158.80
52-Week Range
$115.53
Now: $154.39
$165.70
Volume5,900 shs
Average Volume20,087 shs
Market Capitalization$347.38 million
P/E RatioN/A
Dividend Yield1.33%
BetaN/A
iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund's investment advisor is BlackRock Fund Advisors.
Read More

Geographic Exposure of IHE

Currency Exposure of IHE

Sector Exposure of IHE

Industry Exposure of IHE


Basic Details

Issuer iShares
Fund NameiShares US Pharmaceuticals ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:IHE
Inception Date5/1/2006
Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkDow Jones US Select Pharmaceuticals Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$346.68 million
Average Daily Volume$13,513.50
Discount/Premium0.06%

ETF Expenses

Management Fee0.44%
Other Expenses0.00%
Total Expenses0.44%
Fee Waiver0.00%
Net Expenses0.44%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerIMC Chicago

Receive IHE News and Ratings via Email

Sign-up to receive the latest news and ratings for IHE and its competitors with MarketBeat's FREE daily newsletter.

iShares US Pharmaceuticals ETF (NYSEARCA:IHE) Frequently Asked Questions

How has iShares US Pharmaceuticals ETF's stock been impacted by COVID-19 (Coronavirus)?

iShares US Pharmaceuticals ETF's stock was trading at $138.60 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, IHE shares have increased by 11.4% and is now trading at $154.39. View which stocks have been most impacted by Coronavirus.

How often does iShares US Pharmaceuticals ETF pay dividends? What is the dividend yield for iShares US Pharmaceuticals ETF?

iShares US Pharmaceuticals ETF declared a quarterly dividend on Wednesday, March 25th. Stockholders of record on Thursday, March 26th will be paid a dividend of $0.5866 per share on Tuesday, March 31st. This represents a $2.35 annualized dividend and a yield of 1.52%. The ex-dividend date of this dividend is Wednesday, March 25th. This is a boost from iShares US Pharmaceuticals ETF's previous quarterly dividend of $0.51. View iShares US Pharmaceuticals ETF's dividend history.

Has iShares US Pharmaceuticals ETF been receiving favorable news coverage?

News stories about IHE stock have trended somewhat negative this week, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. iShares US Pharmaceuticals ETF earned a news impact score of -1.3 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news about iShares US Pharmaceuticals ETF.

What other stocks do shareholders of iShares US Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares US Pharmaceuticals ETF investors own include Adobe (ADBE), Broadcom (AVGO), Alibaba Group (BABA), Baxter International (BAX), Baidu (BIDU), Biogen (BIIB), Brooks Automation (BRKS), Chemours (CC), Caesars Entertainment (CZR) and DXC Technology (DXC).

Who are iShares US Pharmaceuticals ETF's key executives?

iShares US Pharmaceuticals ETF's management team includes the following people:
  • George G. C. Parker Ph.D., Independent Chairman of the Board of Trustees (Age 78)
  • Michael Arthur Latham, President, Trustee (Age 51)
  • Jack Gee, Chief Financial Officer, Treasurer (Age 57)
  • Geoffrey D. Flynn, Chief Operating Officer, Executive Vice President
  • Amy Schioldager, Executive Vice President (Age 56)
  • Ira P. Shapiro, Vice President, Chief Legal Officer (Age 52)
  • Matt Tucker, Vice President
  • Eilleen M. Clavere, Secretary (Age 61)
  • Cecilia H. Herbert, Independent Trustee (Age 68)
  • Charles A. Hurty, Independent Trustee (Age 73)

What is iShares US Pharmaceuticals ETF's stock symbol?

iShares US Pharmaceuticals ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IHE."

How do I buy shares of iShares US Pharmaceuticals ETF?

Shares of IHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is iShares US Pharmaceuticals ETF's stock price today?

One share of IHE stock can currently be purchased for approximately $154.39.

How big of a company is iShares US Pharmaceuticals ETF?

iShares US Pharmaceuticals ETF has a market capitalization of $347.38 million.

What is iShares US Pharmaceuticals ETF's official website?

The official website for iShares US Pharmaceuticals ETF is www.iShares.com.

This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.